Uppsala, Sweden

Jossan Sukhwinder

This inventor holds 1 USPTO granted patent. Top assignee: Biovitrum Ab. Active years: 2004.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jossan Sukhwinder: Innovator in Pharmaceutical Formulations

Introduction

Jossan Sukhwinder is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of combination formulations for treating diseases related to the 5-HT receptor. Her innovative approach has the potential to enhance therapeutic outcomes for patients in need.

Latest Patents

Jossan holds 1 patent for her invention titled "Pharmaceutical combination formulation and method of treatment with the combination." This patent describes a method for preventing or treating diseases associated with the 5-HT receptor. The invention involves administering a combination of a 5-HT receptor agonist and a 5-HT receptor antagonist to achieve a therapeutic effect. Additionally, it includes a pharmaceutical composition that comprises an effective amount of this combination, along with a pharmaceutically acceptable carrier.

Career Highlights

Jossan Sukhwinder has established herself as a key figure in the pharmaceutical industry. She works at Biovitrum AB, where she continues to innovate and contribute to the development of effective treatments. Her work is characterized by a commitment to improving patient care through scientific advancements.

Collaborations

Jossan collaborates with esteemed colleagues, including Björn M Nilsson and Kjell S Sakariassen. These partnerships enhance her research and development efforts, fostering an environment of innovation and shared expertise.

Conclusion

Jossan Sukhwinder's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…